Rebecca Anhang Price is a doctoral student in the Medical Sociology track of the Ph.D. Program in Health Policy at Harvard University. Rebecca's research interests include the effects of new clinical technologies on health care quality, and evaluation of the effectiveness of health communication programs, including direct-to-consumer advertising. Rebecca has conducted research with physicians and consumers and helped to plan and execute mass media campaigns to promote asthma, HIV and oncology drugs in the United States, and healthy lifestyles in the Middle East. Rebecca graduated from the University of Pennsylvania in 1998 with a BA in Communication, and received a Master of Science in Health Policy and Management from the Harvard School of Public Health in 2003. She is a recipient of the George Bennett Dissertation Fellowship from the Foundation for Informed Medical Decision Making, and the Novartis Fellowship.
Nicole is a third-year student in the Decision Sciences concentration of the Ph.D. Program in Health Policy at Harvard University and the recipient of a traineeship from the National Library of Medicine. Her research interests involve economic evaluation of screening and treatment strategies for infectious diseases in developing countries, and she just finished work that was published in the American Journal of Medicine on the cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV. Prior to enrolling in the doctoral program, she worked as a research assistant at Partners in Health and the Program in Infectious Disease and Social Change at Harvard Medical School. She received a M.S. degree in Health Policy and Management from the Harvard School of Public Health in 2005.
April is a fourth year student in the Ph.D. Program in Health Policy at Harvard University. She served as Senior Project Manager for the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) team for many years before entering the Ph.D. Program. April has collaborated with CEPAC team members by using a computer simulation model to address questions on HIV prevention and treatment interventions in the U.S., France, Côte d'Ivoire, India, the Caribbean, and South Africa. Her research with the team has focused on informing HIV clinical and laboratory monitoring policy both in the U.S. and developing country settings. Her current research focuses on efficiency and ethical considerations in the allocation of resources for HIV/AIDS treatment in developing countries. By combining quantitative, analytical, and research skills, she aims to examine health-related issues at both the technical and policy levels and to convey findings in ways that will influence health policy experts and decision makers. April earned an A.B. in History from Dartmouth College in 1996, and a M.S. in Population and International Health from the Harvard School of Public Health in 2004. She is a former recipient of a Health Policy Training Program Fellowship (AHRQ T32 HS000055) and current recipient of an HIV Clinical Research Fellowship (NIH T32 AI007433).
Chara Rydzak is an M.D./Ph.D. student in Health Policy at Harvard University and at Harvard Medical School (HMS). A recipient of the National Institute of Mental Health Trainee Grant (2004-2006) and the HIV Clinical Research Training Fellowship (2006-2007), she has completed her second year at HMS and a third year of Ph.D. work in the Health Policy program with a concentration in Decision Sciences. She is currently involved in several research projects focusing on the evaluation of diagnosis and treatment of syphilis in pregnant Sub-Saharan African women; the impact of mental health status and domestic violence on earnings of low-income women; and HIV modeling and model calibration of screening, treatment and vaccination strategies. She graduated from Stanford University in 2000 with a B.A. in Human Biology and English and spent two years working as a Research Health Services Specialist for the V.A. Health Care System at Stanford University's Center for Primary Care and Outcomes Research (PCOR) before beginning her M.D.-Ph.D. work at Harvard University.